- 39,121
- 274
Barring a significant scientific breakthrough that would practically eliminate all coronavirus, which pharmasutical companies have zero financial incentive to achieve by the way. The best we can do is push therapeutics. Reduce the impact through preemptive vaccinations and post treatment options and roll out new formulas as soon as a deadlier variant is detected. The jury is still out on this new Omni variant, from the cases I have seen so far it doesn't appear to be that serious. Only producing mild symptoms in vaccinated individuals, the big question is, what's the impact for unvaccinated individuals. There is the potential that it could be way deadlier to the unvaccinated. Which would appear as a win for the pro vaccine crowd. But the question remains, would the variant become such a large problem if people were not vaccinated and capable of being detected sooner through their symptoms.
Think of it this way. Ebola has a death rate of around 50%. One of the major reasons it doesn't become a pandemic is how quickly people get sick. Typically it can be detected quickly because of clusters of sick people and a quarantine can be set up and it burns itself out. Now imagine there was a leaky vaccine for Ebola where the majority of vaccinated people who get it don't have symptoms, and some only mild symptoms, but they can still transmit it. Effective detection and containment becomes near impossible, but the 50% death rate remains a real threat to the unvaccinated. Solution: vaccinate everyone.
